{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:27:58Z","timestamp":1757312878961,"version":"3.30.1"},"reference-count":21,"publisher":"Medknow","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0973-1482.196859","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T04:13:58Z","timestamp":1498104838000},"page":"204","source":"Crossref","is-referenced-by-count":10,"title":["The significance of serum leptin level in patients with early stage nonsmall cell lung cancer"],"prefix":"10.4103","volume":"13","author":[{"given":"Fatih","family":"Karatas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suleyman","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gungor","family":"Utkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Demirkazik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fikri","family":"Icli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0973-1482.196859-1","first-page":"147","volume-title":"Low-dose computed tomographic screening for lung cancer","author":"Christensen","year":"2015","journal-title":"Clin Chest Med"},{"key":"key-10.4103\/0973-1482.196859-2","first-page":"992","volume-title":"New pathologic classification of lung cancer: Relevance for clinical practice and clinical trials","author":"Travis","year":"2013","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.196859-3","first-page":"391","volume-title":"The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC)","author":"Karapanagiotou","year":"2008","journal-title":"Lung Cancer"},{"key":"key-10.4103\/0973-1482.196859-4","first-page":"500","volume-title":"Leptin serum levels in cachectic and non-cachectic lung cancer patients","author":"Werynska","year":"2009","journal-title":"Pneumonol Alergol Pol"},{"key":"key-10.4103\/0973-1482.196859-5","first-page":"90","volume-title":"Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer","author":"Jamieson","year":"2004","journal-title":"Cytokine"},{"key":"key-10.4103\/0973-1482.196859-6","first-page":"22","volume-title":"Hormones of adipose tissue and their biologic role in lung cancer","author":"Ntikoudi","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"key-10.4103\/0973-1482.196859-7","first-page":"346","volume-title":"Serum leptin levels in gastric cancer patients and the relationship with insulin resistance","author":"Begenik","year":"2015","journal-title":"Arch Med Sci"},{"key":"key-10.4103\/0973-1482.196859-8","first-page":"2295","volume-title":"Leptin signaling molecular actions and drug target in hepatocellular carcinoma","author":"Jiang","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"key-10.4103\/0973-1482.196859-9","first-page":"e0123217","volume-title":"Adipocyte secreted factors enhance aggressiveness of prostate carcinoma cells","author":"Moreira","year":"2015","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.196859-10","first-page":"53","volume-title":"Molecular targeting of obesity pathways in cancer","author":"Surmacz","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"key":"key-10.4103\/0973-1482.196859-11","first-page":"1477","volume-title":"High leptin level is an independent risk factor of endometrial cancer: A meta-analysis","author":"Wang","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"key-10.4103\/0973-1482.196859-12","first-page":"39","volume-title":"Adipocyte activation of cancer stem cell signaling in breast cancer","author":"Wolfson","year":"2015","journal-title":"World J Biol Chem"},{"key":"key-10.4103\/0973-1482.196859-13","first-page":"19","volume-title":"Elevated serum leptin levels: A risk factor for non-small-cell lung cancer?","author":"Terzidis","year":"2009","journal-title":"Oncology"},{"key":"key-10.4103\/0973-1482.196859-14","first-page":"507","volume-title":"Clinical significance of serum adipokines levels in lung cancer","author":"Kerenidi","year":"2013","journal-title":"Med Oncol"},{"key":"key-10.4103\/0973-1482.196859-15","first-page":"230","volume-title":"Is leptin a predictive factor in patients with lung cancer?","author":"Song","year":"2014","journal-title":"Clin Biochem"},{"key":"key-10.4103\/0973-1482.196859-16","first-page":"10231","volume-title":"Effects of leptin and leptin receptor gene polymorphisms on lung cancer","author":"Unsal","year":"2014","journal-title":"Tumour Biol"},{"key":"key-10.4103\/0973-1482.196859-17","first-page":"1841","volume-title":"Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: A retrospective analysis","author":"Xu","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"key-10.4103\/0973-1482.196859-18","first-page":"1303","volume-title":"Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial","author":"Schenk","year":"2009","journal-title":"Prostate"},{"key":"key-10.4103\/0973-1482.196859-19","first-page":"207","volume-title":"Leptin biosynthetic pathway in white adipocytes","author":"Cammisotto","year":"2006","journal-title":"Biochem Cell Biol"},{"key":"key-10.4103\/0973-1482.196859-20","first-page":"2073","volume-title":"Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin\/pemetrexed chemotherapy","author":"Mou","year":"2014","journal-title":"Oncol Lett"},{"key":"key-10.4103\/0973-1482.196859-21","first-page":"1122","volume-title":"A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo","author":"Catalano","year":"2015","journal-title":"J Cell Mol Med"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T04:15:54Z","timestamp":1498104954000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cancerjournal.net\/text.asp?2017\/13\/2\/204\/196859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"alternative-id":["196859"],"URL":"https:\/\/doi.org\/10.4103\/0973-1482.196859","relation":{},"ISSN":["0973-1482"],"issn-type":[{"type":"print","value":"0973-1482"}],"subject":[],"published":{"date-parts":[[2017]]}}}